TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 74 filers reported holding TRINITY BIOTECH PLC in Q4 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,783,000 | +18.9% | 134,894 | +2.0% | 0.12% | +24.7% |
| Q2 2016 | $1,500,000 | -39.3% | 132,268 | -37.6% | 0.09% | -39.2% |
| Q1 2016 | $2,472,000 | +13.0% | 212,007 | +14.0% | 0.15% | +21.4% |
| Q4 2015 | $2,188,000 | +30.5% | 186,047 | +27.0% | 0.13% | +34.0% |
| Q3 2015 | $1,676,000 | -36.9% | 146,525 | -0.3% | 0.09% | -31.4% |
| Q2 2015 | $2,654,000 | -4.9% | 146,982 | +1.4% | 0.14% | -12.7% |
| Q1 2015 | $2,791,000 | +8.6% | 145,008 | -1.2% | 0.16% | +10.6% |
| Q4 2014 | $2,569,000 | +19.5% | 146,711 | +24.7% | 0.14% | +16.4% |
| Q3 2014 | $2,150,000 | -6.8% | 117,661 | +17.5% | 0.12% | +0.8% |
| Q2 2014 | $2,306,000 | -5.5% | 100,131 | -0.5% | 0.12% | -14.2% |
| Q1 2014 | $2,439,000 | -8.0% | 100,667 | -4.5% | 0.14% | -8.4% |
| Q4 2013 | $2,650,000 | -9.6% | 105,424 | -21.7% | 0.15% | -23.4% |
| Q3 2013 | $2,930,000 | +19.8% | 134,671 | -7.2% | 0.20% | +6.9% |
| Q2 2013 | $2,445,000 | – | 145,101 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |